Multiply resistant nontyphoidal Salmonella gastroenteritis in children. 1993

E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
Infectious Diseases Service, Hospital de NiƱos Dr. Ricardo Gutierrez, Buenos Aires, Argentina.

From January, 1990, to December 31, 1990, 75 children with multiply resistant Salmonella gastroenteritis were studied at the Children's Hospital "Ricardo Gutierrez" of Buenos Aires. These children ranged from 1 month to 15 years of age. Infection was community-acquired in 20 (26.6%), nosocomially acquired in 50 (66.7%) and undetermined in 5. Thirty-nine (52%) had grossly bloody stools. Fever occurred at some point in the clinical course in 61 children (81.3%) with a duration of 1 to 33 days (mean, 6.7 days). The duration of diarrhea (1 to 69 days) was longer in those who developed complications (P < 0.001). Six (8%) developed enterocolitis (2 with bowel perforation), 1 had a pulmonary abscess and 8 (11.4%) had bacteremia; 4 children died (5.3%). Salmonella typhimurium was the most common serovar (85.3%). Ninety percent minimum inhibitory concentration studies demonstrated that all strains were resistant to ampicillin (> 128 micrograms/ml), cephalothin (> 128 micrograms/ml), cefuroxime (> 128 micrograms/ml), nalidixic acid (> 256 micrograms/ml), rifampin (> 256 micrograms/ml), gentamicin (> 256 micrograms/ml) and tobramycin (256 micrograms/ml); 77.3% of strains were resistant to ceftazidime (32 micrograms/ml), 97.6% to netilmicin (> 256 micrograms/ml), 92.8% to amikacin (256 micrograms/ml), 24.4% to isepamicin (32 micrograms/ml), 5.3% to chloramphenicol (4 micrograms/ml) and 2.7% to cefoxitin (2 micrograms/ml). The 90% minimum inhibitory concentration of cefotaxime and ceftazidime was reduced by the addition of clavulanate. Aggressive multiply resistant Salmonella strains are a major pediatric problem in Buenos Aires.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D005759 Gastroenteritis INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER. Gastroenteritides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
September 2021, Microbiology spectrum,
E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
January 1995, Drugs,
E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
March 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
April 2002, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
March 2007, Emerging infectious diseases,
E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
March 2014, Foodborne pathogens and disease,
E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
January 2017, Journal of infection and public health,
E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
October 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
January 1988, APMIS. Supplementum,
E Maiorini, and E L Lopez, and A L Morrow, and F Ramirez, and A Procopio, and S Furmanski, and G M Woloj, and G Miller, and T G Cleary
January 1998, The Turkish journal of pediatrics,
Copied contents to your clipboard!